Patent details

EP3311835 Title: ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3311835
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171870975
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGENTS FOR THE TREATMENT OF CANCER
French Title of Invention:
ADMINISTRATION DE PROMÉDICAMENTS ACTIVÉS PAR HYPOXIE ET D'AGENTS ANTI-ANGIOGÉNIQUES POUR LE TRAITEMENT DU CANCER
German Title of Invention:
VERABREICHUNG VON HYPOXIE-AKTIVIERTEN PRODRUGS UND ANTIANGIOGENEN WIRKSTOFFEN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
11/07/2011
Grant date:
24/03/2021
EP Publication Date:
25/04/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/03/2021
EP B1 Publication Date:
24/03/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/07/2021
Expiration date:
11/07/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/06/2021
 
 

Name:
ImmunoGenesis, Inc.
Address:
909 Fannin, Suite 2000, Houston, TX 77010, United States (US)

History of Owners

From:
17/03/2021
To:
25/06/2021

Name:
Threshold Pharmaceuticals Inc.
Address:
170 Harbor Way Suite 300 A 94080, San Francisco, CA 94080, United States (US)

Inventor

1

Name:
KROLL, Stewart
Address:
United States (US)

2

Name:
CURD, John
Address:
United States (US)

3

Name:
SUN, Jessica
Address:
United States (US)

4

Name:
HART, Charles
Address:
United States (US)

Priority

1

Priority Number:
363610 P
Priority Date:
12/07/2010
Priority Country:
United States (US)

2

Priority Number:
201161470412 P
Priority Date:
31/03/2011
Priority Country:
United States (US)

3

Priority Number:
201161470812 P
Priority Date:
01/04/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/404; A61K 31/4045; A61K 31/436; A61K 31/44; A61K 31/4412; A61K 31/506; A61K 31/665; A61K 31/675; A61K 39/395; A61K 45/06; A61P 35/00; A61P 35/02; A61P 43/00;

Publication

European Patent Bulletin

1

Issue number:
202112
Publication date:
24/03/2021
Description:
Grant (B1)

2

Issue number:
202130
Publication date:
28/07/2021
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages